Climatotherapy of atopic dermatitis at the Dead Sea: Demographic evaluation and cost-effectiveness

International Journal of Dermatology

Volumn 39, Issue 1, 2000, Pages 59-69

  Harari, Marco ^a   Shani, Jashovam ^b   Seidl, Vladimir ^b   Hristakieva, Eugenia ^b  

^a DMZ Rehabilitation Clinic   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALOE VERA EXTRACT; ANTIBIOTIC AGENT; BETAMETHASONE; CETIRIZINE; CHLORPHENIRAMINE; CROMOGLYCATE DISODIUM; CYCLOSPORIN; DESONIDE; DOXEPIN; MICONAZOLE; PSORALEN; RANITIDINE; RECOMBINANT GAMMA INTERFERON; THYMOPENTIN;

ACNE; ADOLESCENT; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CHILD; CHILL; CLIMATOTHERAPY; COST EFFECTIVENESS ANALYSIS; DROWSINESS; DRY SKIN; ERYTHEMA; FEMALE; FOLLICULITIS; HEADACHE; HERPES; HUMAN; HYPERPIGMENTATION; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; PARESTHESIA; RETROSPECTIVE STUDY; SEA; TREATMENT OUTCOME; XEROSIS;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DERMATITIS, ATOPIC; FEMALE; HELIOTHERAPY; HUMANS; ISRAEL; MALE; RELAXATION TECHNIQUES; RETROSPECTIVE STUDIES; SEAWATER; SEX FACTORS; SUNLIGHT; THALASSOTHERAPY; TREATMENT OUTCOME;

EID: 0034048402     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2000.00840.x     Document Type: Article

References (61)

1. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994; 102: 128-137.
2. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; 92: 44-47.
3. Rothe MJ, Grant-Kels JM. Atopic dermatitis: an update. J Am Acad Dermatol 1996; 35: 1-13.
4. Rudikoff D, Lebwohl M. Atopic dermatitis (Seminar). Lancet 1998; 351: 1715-1721.
5. Dotterud LK, Kammen B, Lund E, et al. Prevalence and some clinical aspects of atopic dermatitis in Sor-Varanger. Acta Derm Venereol (Stockh) 1995; 75: 50-53.
6. Uehara M, Kimura C. Descendant family history of atopic dermatitis. Acta Derm Venereol (Stockh) 1993; 73: 62-63.
7. Lapidus CS, Honig PJ. Atopic dermatitis. Pediatr Rev 1994; 15: 327-332.
8. Williams HC, Strachan DP, Hay RJ. Childhood eczema: disease of the advantaged. Br Med J 1994; 308: 1132-1135.
9. Morren MA, Przybilla B, Bamelis M, et al. Atopic dermatitis: triggering factors. J Am Acad Dermatol 1994; 31: 467-473.
10. Gupta MA, Gupta AK, Schork NJ, et al. Depression modulates pruritus perception: a study of pruritus in psoriasis and atopic dermatitis. Psychosom Med 1994; 56: 36-40.
11. Nevot S, Lleonart R, Casas R. Atopic dermatitis today. Allergol Immunopathol 1997; 25: 203-208.
12. Apter AJ, Rothe MJ, Grant-Kels JM. Allergy consultation in the management of atopic dermatitis. Pediatr Dermatol 1991; 8: 341-347.
13. Sigurs N, Hattevig G, Kjellman B, et al. Appearance of atopic disease in relation to serum IgE antibodies in children followed up from birth for 4-15 years. J Allergy Clin Immunol 1994; 94: 757-763.
14. Pene J, Rousset F, Briere F, et al. IgE production by normal human lymphocytes is induced by interleukin-4 and suppressed by interferons-α and prostaglandin-E2. Proc Natl Acad Sci USA 1988; 85: 6880-6884.
15. Sichel JP. Schultz's method of relaxation in asthma in children. Rev Neuropsychiatr Infant 1973; 21: 529-541.
16. Kushelevsky A, Harari M, Kudish AI, et al. Safety of solar phototherapy at the Dead Sea. J Am Acad Dermatol 1998; 38: 447-452.
17. Seidl V, Harari M, Weinrauch L. Climatotherapy of atopic dermatitis at the Dead-Sea. Der Deutsch Dermatol 1993; 41: 841-884.
18. Nilsson EJ, Henning CG, Magnusson J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol 1992; 27: 29-34.
19. Lever R, Hadley K, Downey D, Mackie R. Staphylococcal colonization in atopic dermatitis and effect of topical mupirocin therapy. Br J Dermatol 1988; 119: 189-198.
20. Leung DYM. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995; 96: 302-318.
21. Drake L, Fallen JD, Sober A, et al. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. J Am Acad Dermatol 1994; 31: 613-616.
22. Brehler R, Hildebrand A, Luger TA. Recent developments in the treatment of atopic eczema. J Am Acad Dermatol 1997; 36: 983-994.
23. Bos JD, Wierenga EA, Sillevis SJH, et al. Immune dysregulation in atopic eczema. Arch Dermatol 1992; 128: 1509-1512.
24. Hanifin JM, Schneider LC, Leung DYM, et al. Recombinant interferon-gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993; 28: 189-197.
25. Nishioka K, Matsunaga T, Katayama I. Gamma-interferon for severe cases of atopic dermatitis of the adult type. J Dermatol 1995; 22: 181-185.
26. Pung YH, Vetro SW, Bellanti JA. Use of interferons in atopic (IgE-mediated) diseases. Ann Allergy 1993; 71: 234-238.
27. Jekler J, Larko O. UVA solarium versus UVB phototherapy of atopic dermatitis: a paired-comparison study. Br J Dermatol 1991; 125: 569-572.
28. Krutmann J, Czech W, Diepgen T, et al. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992; 26: 225-230.
29. George A, Bilsland DJ, Johnson BE, et al. Narrow-band (TL-01) UVB air-conditioned phototherapy for chronic severe adult atopic dermatitis. Br J Dermatol 1993; 12: 49-56.
30. Zimmermann J, Utermann S. Photo-brine therapy in patients with psoriasis and neurodermatitis atopica. Hautarzt 1994; 45: 849-853.
31. Guhring H. Complex high altitude climate therapy for children and adolescents with neurodermatitis atopica. Kinderarztliche Praxis 1992; 60: 150-155.
32. Steiger T, Borelli S. Climatic factors in the treatment of atopic eczema. In: Ruzicka T, Ring J, Przybilla B, eds. Handbook of Atopic Eczema. Berlin: Springer-Verlag, 1991: 415-428.
33. Zug KA, McKay M. Eczematous dermatitis: a practical review. Am Fam Phys 1996; 54: 1243-1250.
34. Harari M, Friedland D, Kaznncheeva L, et al. Dead-Sea factors in treating atopic dermatitis. In press.
35. Koblenzer CS. Psychotherapy for intractable inflammatory dermatoses. J Am Acad Dermatol 1995; 32: 609-612.
36. Soyland E, Funk J, Rajka G, et al. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis, a double-blind, multicenter study. Br J Dermatol 1994; 130: 757-764.
37. Fiocci A, Sela M, Signoroni P, et al. The efficacy and safety of gamma-linolenic acid in the treatment of infantile atopic dermatitis. J Int Med Res 1994; 22: 24-32.
38. Berth-Jones J, Graham-Brown R. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet 1993; 341: 1557-1560.
39. Mabin DC, Sykes AE, David TJ. Controlled trial of a few food diets in severe atopic dermatitis. Arch Dis Child 1995; 73: 202-207.
40. Halbert AR, Weston WL, Morelli JG. Atopic dermatitis: is it an allergic disease? J Am Acad Dermatol 1995; 33: 1008-1018.
41. Johnson E, Irons J, Patterson R, et al. Serum IgE concentration in atopic dermatitis. J Allergy Clin Immunol 1974; 54: 94-99.
42. Diepgen TL, Fartasch M. Recent epidemiological and genetic studies in atopic dermatitis. Acta Derm Venereol (Suppl) (Stockh) 1992; 176: 13-18.
43. Johansson SGO, Juhlin L. Immunoglobulin E in healed atopic dermatitis and after treatment with corticosteroids and azathioprine. Br J Dermatol 1970; 82: 10-12.
44. Charpin J. Allergologie, 2nd edn. Paris, France: Flammarion Publishers, 1986: 1019.
45. Baillet P. Dosage des immunoglobulines E et cure thermale a la Roche-Posay. Presse Therm Clin 1984; 121: 228-229.
46. Harari M, Barzillai R, Shani J. Magnesium in the management of asthma: critical review of acute and chronic treatments, and DMZ's clinical experience at the Dead-Sea. J Asthma 1998; 35: 525-536.
47. Salpietro DC, Naccari F, Polimenti I, Pellegrino C. Reduced plasma c-AMP levels in children with atopic dermatitis. Pediatr Allergy Immunol 1998; 9: 130-132.
48. Sawai T, Ikai K, Uehara M. cAMP phosphodiesterase activity in peripheral blood mononuclear leucocytes from patients with atopic dermatitis: correlation with respiratory atopy. Br J Dermatol 1998; 138: 846-848.
49. Rajka G. Essential aspects of atopic dermatitis. In: Rajka G, ed. Berlin: Springer-Verlag, 1989: 57-69.
50. Schafer T, Dockery D, Kramer U, et al. Experiences with the severity scoring of atopic dermatitis in a population of German children. Br J Dermatol 1997; 137: 558-562.
51. Berth-Jones J. Six area, six sign atopic dermatitis (SASSAD) severity score: a system for monitoring disease activity in atopic dermatitis. Br J Dermatol 1996; 48 (Suppl. 135): 25-30.
52. Bahmer FA. ADASI score: atopic dermatitis area and severity index. Acta Derm Venereol (Suppl) (Stockh) 1992; 176: 32-33.
53. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol (Suppl) (Stockh) 1989; 144: 13-14.
54. Salek MS, Finlay AY, Luscombe DK, et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis: a randomized, double blind, placebo-controlled trial. Br J Dermatol 1993; 129: 422-430.
55. Van Joost T, Heule F, Korstanje M, et al. Cyclosporin in atopic dermatitis: a multicenter placebo-controlled study. Br J Dermatol 1994; 130: 634-640.
56. Hsieh KH, Shaio MF, Liao TN. Thymopentin treatment in severe atopic dermatitis, clinical and immunological evaluations. Arch Dis Child 1992; 67: 1095-1102.
57. Su JA, Kamp AS, Varigos GA, Nolan TM. Atopic eczema, its impact on the family and financial cost. Arch Dis Child 1997; 76: 159-162.
58. Herd RM, Tidman MJ, Prescott RJ, Hunter JA. The cost of atopic eczema. Br J Dermatol 1996; 135: 20-23.
59. Lapidus CS, Schwarz DF, Honig PJ. Atopic dermatitis in children: who cares, who pays? J Am Acad Dermatol 1993; 28: 699-703.
60. Nuovo J, Ellsworth AJ, Larson B. Treatment of atopic dermatitis with antihistamines: lessons from a randomized clinical trial. J Am Board Fam Pract 1992; 5: 137-141.
61. Shani J, Harari M, Hristakieva E, et al. Dead-Sea climatotherapy versus other modalities of treatment for psoriasis: comparative cost-effectiveness. Int J Dermatol 1999; 38: 252-262.